GSE130401 trametinib YAP 6 v 3 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE130401_trametinib_YAP_6_v_3_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE130401_trametinib_YAP_6_v_3_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE130401_trametinib_YAP_6_v_3_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE130401_trametinib_YAP_6_v_3_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

GABPB1 intronic transcript

Gene

PCBP1 antisense RNA 1

Gene

LBX2 antisense RNA 1

Gene

TTN antisense RNA 1

Gene

prostate cancer associated transcript 7

Gene

SOCS2 antisense RNA 1

Gene

palmitic acid regulated anti-inflammatory lncRNA

Gene

family with sequence similarity 66 member B

Gene

long intergenic non-protein coding RNA 863

Gene

glioblastoma down-regulated RNA

  • Gene

    GABPB1 intronic transcript


  • Gene

    PCBP1 antisense RNA 1


  • Gene

    LBX2 antisense RNA 1


  • Gene

    TTN antisense RNA 1


  • Gene

    prostate cancer associated transcript 7


  • Gene

    SOCS2 antisense RNA 1


  • Gene

    palmitic acid regulated anti-inflammatory lncRNA


  • Gene

    family with sequence similarity 66 member B


  • Gene

    long intergenic non-protein coding RNA 863


  • Gene

    glioblastoma down-regulated RNA

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.